Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyDrHank vs Prime Doctor RX

MyDrHank
Graded #109

Lower grade

vs+4.8
Prime Doctor RX
Graded #84

Higher grade

The verdict

Prime Doctor RX takes it — 73/100 to 68.2/100.

Prime Doctor RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its whole ladder and honors its own asterisk — then bills every 28 days and labels every price per month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyDrHank +8
70
62
Dose & formulationMyDrHank +2
84
82
Clinical oversightPrime Doctor RX +14
66
80
Labs & monitoringPrime Doctor RX +28
50
78
FulfillmentMyDrHank +6
78
72
Contract termsPrime Doctor RX +12
48
60
MyDrHank · left barPrime Doctor RX · right bar

The numbers

MetricMyDrHankPrime Doctor RX
WeighScore68.2/10073/100
GradeCC
Scorecard rank#109#84
Semaglutide$249/mo oral, $259/mo injectable$249 every 4 weeks (thirteen charges a year, not twelve)
Tirzepatide$349/mo$339 every 4 weeks (thirteen charges a year, not twelve)
Coverage44 states (KS, LA, MS, NM, ND, WV excluded)Not publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
MyDrHank

Graded #109 · C

Strengths

  • Prices are published openly on the product pages, before any intake quiz — most compounded competitors gate the number behind a questionnaire
  • A real oral semaglutide tablet ($249/mo month-to-month) beside the weekly injection, so the needle is optional on the semaglutide line
  • The GLP-1 pages state the price stays the same at every dose, so titrating up does not raise the monthly cost
  • Six prescription lines on one account — weight loss, longevity, peptides and NAD+, sexual health, hair growth and strength — with free shipping included
  • Clean against the FDA warning-letter database: no letter on file under the brand, the entity or the domain

Where it loses points

  • Every price MyDrHank displays is the twelve-month prepay rung — its price component renders the cheapest term in the ladder, so the month-to-month rate ($259 semaglutide, $349 tirzepatide) appears on no page on the site
  • Month-to-month, it is expensive: $259 semaglutide against a $179 median across the providers here that disclose one, and $349 tirzepatide against a $249 median
  • One advertised price is purchasable at no tier — a footnote quotes "$200/mo for compounded tirzepatide" when the cheapest tirzepatide rung is $240, and the "$171/mo" beside it is the oral product's yearly rate, not injectable semaglutide's ($178)
  • An FAQ describes a twelve-month prepay rate as a plan with "no contract"
  • Compounded only and not FDA-approved — no brand Wegovy, Ozempic, Zepbound or Mounjaro lane at any price
  • The operating entity is named — Dr. Hank, LLC, credited in the privacy policy and terms of use — but nobody clinical is: no medical director or prescriber appears anywhere, no lab or monitoring program is published, and the compounding pharmacy is described only as "an FDA-registered U.S. pharmacy"
  • The trust row reads "HIPAA-aware", not HIPAA-compliant — a hedge worth noticing on a site handling prescription intake
  • No served-states list appears on the consumer site; the affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia
Prime Doctor RX

Graded #84 · C

Strengths

  • The full ladder for all three weight-loss products and for TRT sits on the homepage before any intake
  • The asterisk is honored: every card's footnote says the starting price is the 52-week prepay, in full
  • The four-week shipping cycle is disclosed in that same footnote rather than left to a bank statement
  • Names OpenLoop Health as the group providing telehealth evaluation and prescribing
  • Hormone-care initial labs are priced at $50 rather than left unstated

Where it loses points

  • Its own arithmetic proves the 28-day cycle — $3,497 divided by thirteen is exactly $269, and nothing on the page divides cleanly by calendar months
  • A year of month-to-month tirzepatide therefore costs $4,407, not the $4,068 that per-month pricing implies
  • The $269 and $179 headlines are 52-week prepays; month to month they are $339 and $249
  • The Terms of Service name no company, no LLC and no address, and state availability is confirmed only during the intake
  • The $50 lab fee sits in a "how it works" step rather than in the pricing table

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard